Atrial arrhythmia burden as an endpoint in clinical trials: is it the best surrogate? Lessons from a multicenter defibrillator trial.

Cardiac electrophysiology review

Volumn 7, Issue 4, 2003, Pages 355-358

  Euler, David E ^a   Friedman, Paul A ^a  

^a MEDTRONIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; HUMANS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; TACHYCARDIA, VENTRICULAR;

EID: 4143146233     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CEPR.0000023138.85821.63     Document Type: Article

References (0)